Background: Studies show that repeated nicotine use associates with high alcohol consumption in humans and that nicotine exposure sometimes increases alcohol consumption in animal models. However, the relative roles of genetic predisposition to high alcohol consumption, the alcohol drinking patterns, and the timing of nicotine exposure both with respect to alcohol drinking and developmental stage remain unclear. The studies here manipulated all these variables, using mice selectively bred for differences in free-choice (FC) alcohol consumption to elucidate the role of genetics and nicotine exposure in alcohol consumption behaviors.
A LCOHOL USE DISORDERS (AUDs) and tobacco use are highly comorbid, with an estimated 80 to 90% of alcoholics being tobacco users (Miller and Gold, 1998) . Conversely, tobacco users are more likely to consume alcohol, with an estimated 90% of tobacco users being regular alcohol drinkers (Keenan et al., 1990) . Chronic tobacco and alcohol co-use leads to multiplicative negative consequences such as greater risk of developing cancers (Talamini et al., 1999) and greater relapse rates to alcohol drinking and tobacco use compared to the use of either drug alone (McKee and Weinberger, 2013) .
The factors that contribute to the high comorbidity between AUDs and tobacco use are unclear. Epidemiological studies show that tobacco users find alcohol more reinforcing, consume more alcohol, and are more likely to engage in binge drinking than nonusers (McKee et al., 2004) . Studies have shown that the initiation of tobacco use may precede the initiation of alcohol use by months to years and that an earlier age of tobacco use initiation is associated with heavier future drinking (Chen et al., 2002; Grant, 1998) . This suggests that tobacco use may act as a gateway to more severe alcohol drinking. However, some studies show that the initiations of tobacco and alcohol use often overlap in many individuals and that individuals who co-use tobacco and alcohol tend to consume more alcohol (Grant, 1998) . Taken together, these epidemiological findings suggest that the effects of tobacco use alone and the effects of tobacco and alcohol co-use on future alcohol use severity are difficult to dissociate. Furthermore, epidemiological studies are correlational and do not show whether tobacco use and/or tobacco and alcohol co-use has a causative effect on future alcohol use severity.
Animal models have been useful in improving our understanding of the effects of nicotine on alcohol use. Studies in rodents have shown that repeated nicotine injections were given just prior to alcohol access augment alcohol free-choice (FC) drinking or operant self-administration (OSA) behaviors (Lê et al., 2003; Sajja and Rahman, 2012) . These findings suggest that repeated nicotine and alcohol co-exposure may increase alcohol reinforcement and drinking, consistent with the epidemiological findings reviewed above.
Other studies in rodents have investigated the effects of repeated nicotine preexposure in alcohol-na€ ıve animals on subsequent (days to weeks) FC drinking or OSA. These studies were designed to mimic the order of exposure in many cousers of tobacco and alcohol, in which initiation of tobacco use precedes alcohol use and tobacco and alcohol co-use. The findings in this line of research have been varied, with reports of repeated nicotine preexposure having augmenting effects (Locker et al., 2016; Potthoff et al., 1983) or no effect (Kemppainen et al., 2009; Smith et al., 1999 ) on subsequent alcohol drinking or OSA.
In humans, the effects of tobacco use on alcohol intake may depend on the pattern of alcohol use behavior (Weitzman and Chen, 2005) . Although a variety of alcohol use patterns are increased across the board in smokers compared to nonsmokers, binge drinking, defined as a session of heavy drinking that produces blood alcohol concentrations (BACs) ≥ 0.08 g/dl in 2 hours, is a more frequent form of drinking behavior than other patterns of drinking in smokers (McKee and Weinberger, 2013) . In rodents, the effects of chronic nicotine on alcohol intake also seem to depend on the pattern of alcohol access. In mice, several days of nicotine preexposure has been shown to increase binge-like drinking (Locker et al., 2016) , using a limited-access paradigm termed "drinking-in-the-dark" (DID), which produces BACs ≥ 0.08 g/dl in 2 hours in C57BL/6J inbred mice (Rhodes et al., 2005 (Rhodes et al., , 2007 . However, the effects of repeated nicotine on FC drinking have not been explored in mice, perhaps because intake during FC drinking tends to result in relatively modest BACs below the 0.08 g/dl level, even in the high-drinking C57BL/ 6J mouse (Matson and Grahame, 2013) . In rats, repeated nicotine injections have been shown to increase (Blomqvist et al., 1996) or have no effect (Kemppainen et al., 2009 ) on FC drinking. However, the effects of chronic nicotine on binge-like drinking in rats are unknown, primarily due to a lack of reliable voluntary binge-like drinking procedures in rats (Hosov a and Spear, 2017) . To our knowledge, the effects of chronic nicotine on both FC and binge-like drinking have not been compared in the same species.
Genetic factors contribute to the use and co-use of tobacco and alcohol in humans (Madden and Heath, 2002) . Studies in animal models also show that common genetic factors contribute to alcohol-and nicotine-motivated behaviors. For example, selectively bred alcohol-preferring (P) rats are more sensitive to nicotine reinforcement than nonpreferring (NP) and Wistar rats (Hauser et al., 2014; Lê et al., 2006) . In addition, inbred strains of mice with a genetic predisposition for higher alcohol drinking also consume more nicotine (Robinson et al., 1996) . However, the role of genetic predisposition in chronic nicotine's effects on alcohol drinking requires further study to identify risk factors and targeted treatments for addiction.
This study had 4 experiments designed to address 3 main goals. The first goal was to explore the role of genetic propensity toward alcohol preference in nicotine-alcohol interactions. We used mice selectively bred (from the HS/ IBG progenitor stock of heterogeneous mice) for high (HAP2) or low (LAP2) preference for alcohol in a continuous FC paradigm (Grahame et al., 1999; Oberlin et al., 2010) . We hypothesized that HAP2 mice would be more sensitive to the effects of chronic nicotine on alcohol drinking than LAP2 mice based on previous studies indicating genetic overlap between alcohol and nicotine-motivated behaviors (Hauser et al., 2014; Lê et al., 2006; Robinson et al., 1996) .
The second goal was to compare temporal parameters of repeated nicotine injections, either together with (co-exposure model) or prior to alcohol access (preexposure model) on binge-like and FC drinking behavior in mice. The bingelike drinking procedure used in this study is a variant of the DID procedure mentioned previously (Rhodes et al., 2007) . For FC drinking, the procedure used in this study has been shown to produce pharmacologically relevant (>0.1 g/l) levels of alcohol drinking across the dark phase of the lightdark cycle in HAP2 mice (Matson and Grahame, 2013) . Based on the studies reviewed above, we hypothesized that repeated nicotine injections concurrent with alcohol access (co-exposure) would produce a more robust augmentation of subsequent alcohol drinking than repeated nicotine injections prior to alcohol access (preexposure). We also hypothesized that both co-and preexposure to repeated nicotine would have a greater effect on binge-like than FC drinking.
The third goal was to compare age of nicotine preexposure (adolescent vs. adult) on subsequent binge-like and FC drinking in mice. Adolescence is a unique period during which the brain is highly malleable by drugs (Spear, 2016) ; however, studies in adolescent rodents have indicated conflicting results. For example, in a study in which adolescent mice were given 22 hours per day access to nicotine drinking solution or water and 2 hours per day access to water (first 6 days) and alcohol (subsequent 4 days) for 10 days, mice that were given nicotine solution showed greater alcohol intake (DID procedure) than mice in the water group (Locker et al., 2016) . In a rat study in which adolescent animals were given repeated nicotine or saline injections and received FC access to alcohol in adulthood, no differences were observed between the nicotine and saline groups (Kemppainen et al., 2009) . Based on these studies and other findings that show that adolescents are more sensitive than adults to drugs' long-term effects (Spear, 2016) , we hypothesized that nicotine preexposure during adolescence would produce a greater augmentation of alcohol drinking than preexposure during adulthood and that this effect would be more evident in the DID procedure.
We focused our studies on female mice. A body of accumulating evidence suggests that females are more sensitive to nicotine's effects than males, possibly due to hormonal differences between the sexes (Lynch et al., 2002) . In humans, women tend to become nicotine dependent faster and typically have lower success rates in smoking cessation than men (Pogun et al., 2017) . Female C57BL/6J mice consume more nicotine, and show greater escalation of consumption over time and greater withdrawal symptoms, than male mice (Locklear et al., 2012) . Female rats show greater motivation to self-administer nicotine than male rats (Donny et al., 2000) . Additionally, the heritability of smoking has been shown to be higher in women than in men (Pogun et al., 2017) and alcohol intake is higher in female HAP2 and LAP2 mice than in males (Chester and Weera, 2017; Oberlin et al., 2010) ; thus, the use of females might improve the detection of nicotine-alcohol interactive effects in HAP2 and LAP2 mice.
MATERIALS AND METHODS

Subjects
Experimentally na€ ıve female HAP and LAP mice from replicate line 2 (HAP2 and LAP2) were used in Experiments 1 to 3, and female HAP2 mice were used in Experiment 4. For Experiments 1, 2, and 3, mice were generated and tested at Purdue University using breeders obtained from the Indianapolis Alcohol Research Center (IARC). For Experiment 4, mice were generated and tested at the IARC. All mice were weaned between postnatal day (PND) 21 and 23 and housed with same-sex littermates in clear polycarbonate cages (11.5 9 7.5 9 5 in) in groups of 2 to 4 until the start of drinking procedures. During all drinking procedures, mice were singly housed in a reversed 12:12 light-dark cycle and were given 14 days to habituate to the housing environment before the start of drinking procedures. Mice had access to food and water ad libitum, except during DID.
Ages reported are ages at the start of experimental procedures (at the start of drinking in Experiments 1 and 2; at the start of injections in Experiments 3 and 4). In Experiment 1, HAP2 and LAP2 mice from generations 47 and 52 were between PND 106 and 149. In Experiment 2, HAP2 and LAP2 mice from generations 47 and 50 were between PND 123 and 167. In Experiment 3, HAP2 and LAP2 mice from generation 47 were between PND 35 and 38. In Experiment 4, HAP2 mice from generation 50 were between PND 87 and 93. All procedures were approved by the Purdue University Animal Care and Use Committee.
Drugs
(-)-Nicotine base (Acros Organics, Geel, Belgium) was diluted in 0.9% saline. All nicotine doses are reported as free base. Alcohol was diluted from 95% alcohol (Koptec, King of Prussia, PA) to 10% (FC drinking) and 20% (DID) alcohol solutions in tap water. Nicotine doses were chosen based on prior studies that showed that nicotine injections altered alcohol drinking behaviors (e.g., Sajja and Rahman, 2012) . All injections were given intraperitoneally at 10 ml/kg. Alcohol and water drinking bottles were always read on the cage to prevent spillage.
Experiment 1: The Effects of Repeated Nicotine Injections on Immediate Binge-Like Alcohol Drinking (DID) and on DID After a 14-Day Abstinence Period (Re-Exposure). Figure 1A shows the timeline for the experimental procedures. Mice received 14 days of habituation to single housing and reversed light-dark cycle, 4 days of DID acquisition, 3 days of habituation (saline) injections, 10 days of nicotine (0.5 or 1.5 mg/kg) or saline injections immediately before DID, a 14 days abstinence period, and 2 days of reexposure to DID. Mice were assigned to experimental groups (0.0 [saline], 0.5, or 1.5 mg/kg nicotine) in a counterbalanced fashion based on their 2-hour alcohol intake on the third day of habituation injections (Kasten et al., 2015) . Nicotine injection procedures were modeled after the procedures of Sajja and Rahman (2012) , who showed that repeated nicotine injections increased limited-access 2-bottle choice drinking in C57BL/6J mice.
For the DID procedure, standard water bottles were replaced with 1 bottle of 20% alcohol 3 hours into the dark cycle for 2 hours. Alcohol drinking bottles were made from 10-ml serological pipettes fitted with stainless steel sipper tubes. Meniscus readings were accurate to 0.1 ml. During habituation and nicotine/saline treatment, injections were given immediately before alcohol presentation. Alcohol intakes were recorded at 1 and 2 hours postinjection. Mice were weighed immediately before injections and received fresh alcohol daily during the DID procedure.
After the last day of nicotine injections, mice from the second replication of this experiment were retained for 14 days with access to water only (in regular water bottles) and then were re-exposed to 2 days of DID to assess potential effects of the prior chronic nicotine and alcohol co-exposure on binge-like alcohol drinking after a 14-day abstinence period. The rationale for this approach was to assess potential long-term effects of nicotine and alcohol co-exposure on binge-like drinking. Mice were given 14 days of abstinence to prevent potentially confounding effects of acute alcohol and/or nicotine withdrawal.
Experiment 2: The Effects of Repeated Nicotine Injections on
Immediate FC Drinking and on FC Drinking After a 14-Day Abstinence Period (Re-Exposure). Figure 2A shows the timeline for the experimental procedures. Mice received 14 days of habituation to single housing and reversed light-dark cycle, 14 days of acquisition of FC drinking, 3 days of habituation (saline) injections, 9 days of nicotine (0.5 or 1.5 mg/kg) or saline injections at 3 hours into the dark cycle, a 14-day abstinence period, and 6 days of re-exposure to FC drinking. During the acquisition and re-exposure phases, mice were given 1 bottle of water and 1 bottle of 10% alcohol in 25-ml graduated plastic cylinders fitted with stainless steel sipper tubes. Meniscus readings were accurate to 0.5 ml. Alcohol and water were replaced and bottle positions were swapped every 2 days to prevent development of side preference. After 14 days of acquisition of FC drinking, 25-ml bottles were replaced by 10-ml bottles (described above) for the habituation and nicotine/saline injections phases of the experiment. Mice still had continuous access to alcohol and water, but intakes were recorded only at 1, 2, and 3 hours after habituation and nicotine/saline injections. Mice were assigned to experimental groups (0.0 [saline], 0.5, or 1.5 mg/kg nicotine) in a counterbalanced fashion based on their 3-hour alcohol intake on the third day of habituation injections. Mice then received 9 consecutive days of nicotine or saline injections at 3 hours into the dark cycle. During habituation and nicotine/saline injections, drinking fluids were replaced daily and mice were weighed immediately before the start of the dark cycle. After the last day of nicotine injections, mice from the second replication of this experiment were retained for 14 days with access to water only (in regular water bottles) and then re-exposed to 6 days of FC drinking to assess potential effects of the prior chronic nicotine and alcohol co-exposure on FC drinking after a 14-day abstinence period. Mice received 9 instead of 10 days of injections as in Experiment 1 due to an injection error on the 10th day of the first replication of this experiment. Drinking data on this day was discarded, and no mice from this replication were retained for the re-exposure. Then, mice in the second replication of this experiment received 9 injections and were retained for the re-exposure drinking test.
Experiment 3: The Effects of Repeated Nicotine Injections During Adolescence on FC Drinking and DID in Adulthood (HAP2 and LAP2 Mice). Figure 3A shows the timeline for the experimental procedures. Group-housed adolescent mice received nicotine (0.5 or 1.5 mg/kg) or saline injections every other day beginning at PND 35 to 38 for 20 days (10 injections total; based on the method of Kemppainen et al., 2009) . Drug treatment groups were counterbalanced across mouse lines and cages. On the day after the final injection, mice were singly housed in reversed 12:12 light-dark cycle and were habituated for 14 days. On PND 69 to 72, regular water bottles were replaced by two 25-ml bottles of 10% alcohol and water for 14 days (FC drinking). Every 2 days, drinking fluids were replaced with fresh alcohol or water, drinking bottle positions were swapped, and mice were weighed. Alcohol and water intakes were recorded daily for the first 6 days and every 2 days from days 8 to 14 of drinking.
At the end of FC drinking, mice remained singly housed with regular water bottles for 14 days, followed by 5 days of exposure to the DID procedure. Mice were given 5 days of DID instead of 2 (Experiment 1) to assess whether adolescent nicotine exposure Fig. 1 . The effects of repeated nicotine injections on immediate binge-like alcohol drinking (DID) and on DID after a 14-day abstinence period (re-exposure). (A) Timeline schematic for Experiment 1. Mice were given alcohol access 2 hours every day except during the 14-day abstinence period. (B-E) DID immediately after nicotine or saline injections. a HAP2 mice that received 1.5 mg/kg nicotine injections showed greater average (across 10 days) alcohol intake than mice that received 0.5 mg/kg nicotine injections (p < 0.05). b HAP2 mice that received 0.5 mg/kg nicotine showed significantly lower alcohol intake than mice that received saline on day 1 of nicotine/saline injections. c HAP2 mice that received 1.5 mg/kg nicotine injections showed greater alcohol intake than mice that received 0.5 mg/kg (p = 0.05) nicotine injections on the first day of DID (hour 1) following a 2-week abstinence period. d HAP2 mice that received 0.5 mg/kg nicotine injections showed greater alcohol intake than mice that received saline injections on the second day of DID (hour 1) following a 14-day abstinence period (p < 0.01). Ns = 13 to 16/line/treatment group (5 to 8/line/treatment group for re-exposure phase).
produced any latent effects on DID. On each day, water bottles were replaced by 1 bottle of 20% alcohol 3 hours into the dark cycle for 2 hours. Alcohol intakes were recorded at the end of the 2-hour drinking session.
Experiment 4: The Effects of Repeated Nicotine Injections in Adulthood on FC Drinking and DID (HAP2 Mice Only). Figure 4A shows the timeline of experimental procedures. This experiment was conducted in Dr. Nicholas Grahame's laboratory at Indiana University-Purdue University Indianapolis in a similar fashion to Experiment 3 except only HAP2 adult mice were used because untreated adult LAP mice usually do not drink enough alcohol in FC drinking to encounter its pharmacological effects (Oberlin et al., 2010) . Also, nicotine treatment did not alter alcohol intake in LAP2 mice in Experiments 1 to 3 (see Results). In addition, adult mice were singly housed during the injection period that started 20 days prior to the start of FC alcohol drinking on PND 87 to 93 (recall that in Experiment 3 mice needed to mature into adulthood before single housing and alcohol drinking exposure).
During FC drinking, mice had access to 10% alcohol and water concurrently from either 25-or 50-ml bottles. Bottles were read daily for the first 9 days, and every third day thereafter. During the 2 hours of DID, mice had access to 20% alcohol from 10-ml serological pipettes fitted with stainless steel sipper tubes. These drinking tubes were clamped to the stainless steel wire cage lid.
Statistical Analyses
Alcohol intake was expressed as grams of alcohol per kilogram of body weight (g/kg). For FC drinking experiments, alcohol preference ratio (volume of alcohol intake [ml]/total fluid intake [ml]) was calculated. All data were analyzed using analysis of variance (ANOVA) in the Statistical Package for Social Sciences software (IBM Corporation, Armonk, NY). Omnibus ANOVA (between-subject factors: line and treatment group; within-subject factors: day and hour, where appropriate) with significant interactions were followed-up by lower order ANOVAs and Tukey's post hoc where appropriate. The significance level was set at p < 0.05. All data are shown as mean AE SEM.
RESULTS
Experiment 1: The Effects of Chronic Nicotine Injections on Immediate Binge-Like Alcohol Drinking (DID) and on DID After a 2-Week Abstinence Period DID During Acquisition and Habituation Injections. Given that DID is not well characterized in HAP and LAP mice, here we report DID in these mice during acquisition and habituation injections. Mean (AESEM) DID intake collapsed across the 4 acquisition days in HAP2 mice was 2.47 AE 0.13 (hour 1) and 1.76 AE 0.17 (hour 2) and, in LAP2 mice, was 0.76 AE 0.09 (hour 1) and 0.82 AE 0.07 (hour 2). Analysis of DID during acquisition (line [2] 9 day [4] 9 hour [2] ANOVA) yielded main effects of line, F(1, 89) = 107.1, p < 0.001; HAP2 > LAP2, and hour, Fig. 2 . The effects of repeated nicotine injections on immediate free-choice (FC) drinking and on FC drinking after a 14-day abstinence period (reexposure). (A) Timeline schematic for Experiment 2. Mice were given FC alcohol access throughout the experiment except during the 14-day abstinence period. (B-D) Immediate postnicotine-alcohol intake and (E-G) alcohol preference over 9 days of FC drinking. HAP2 mice in the 1.5 mg/kg nicotine group showed significantly lower alcohol intake (D) and preference (G) than HAP2 mice in the 0.0 or 0.5 mg/kg nicotine groups in hour 3 postinjection. (H) Alcohol intake and (I) preference over 6 days of FC drinking after a 14-day abstinence period (re-exposure phase). There were no significant effects of treatment on re-exposure FC alcohol intake or preference. All data are presented collapsed by day as there were no significant effects of day. *p < 0.05; (B-G) N = 14 to 17/line/treatment group; (H, I) N = 7 to 8/line/treatment group. Chronic nicotine preexposure had no effect on FC drinking and DID in adult HAP2 mice. All data are presented collapsed by day as there were no significant effects of day. N = 11 to 14/treatment group. F(1, 89) = 8.7, p < 0.005, and a line 9 hour interaction, F(1, 89) = 12.3, p = 0.001. The interaction was due to significantly decreased alcohol intake in the second hour in HAP2 mice, hour effect: F(1, 44) = 12.9, p = 0.001, but not LAP2 mice.
Analysis of DID during habituation injections (line [2] 9 day [3] 9 hour [2] ANOVA) yielded a main effect of line, F(1, 89) = 109.8, p < 0.001; HAP2 > LAP2, and a line 9 hour interaction, F(1, 89) = 5.9, p < 0.05. Mean (AESEM) DID intake collapsed across the 3 habituation days in HAP2 mice was 1.61 AE 0.10 (hour 1) and 1.39 AE 0.10 (hour 2) and, in LAP2 mice, was 0.51 AE 0.06 (hour 1) and 0.64 AE 0.05 (hour 2). DID Immediately After Nicotine or Saline Injections. Across 10 days of nicotine/saline treatment, HAP2 mice in the 1.5 mg/kg nicotine group showed greater alcohol intake than HAP2 mice in the 0.5 mg/kg nicotine group in both hours 1 and 2 across (Fig. 1B,D ). An ANOVA of line (2) 9 treatment (3) 9 day (10) 9 hour (2) yielded significant main effects of line, F(1, 85) = 69.7, p < 0.001, treatment, F(2, 85) = 3.5, p < 0.05, day, F(9, 765) = 4.0, p < 0.001, and hour, F(1, 85) = 9.8, p < 0.005. There were also significant day 9 line, F(9, 765) = 4.6, p < 0.001, day 9 hour, F(9, 765) = 3.3, p = 0.001, line 9 treatment, F (2, 85) = 6.1, p < 0.005, and line 9 treatment 9 day 9 hour, F(18, 765) = 1.7, p < 0.05, interactions. This 4-way interaction was further explored with line 9 treatment 9 day ANOVAs within each hour.
The hour 1 ANOVA yielded significant main effects of line, F(1, 85) = 44.9, p < 0.001; HAP2 > LAP2, and day, F (9, 765) = 2.8, p < 0.005, and significant day 9 line, F(9, 765) = 2.0, p < 0.05, and line 9 treatment, F(2, 85) = 4.9, p = 0.01, interactions. The line 9 treatment interaction was due to a significant main effect of treatment in HAP2 mice only, F(2, 42) = 3.8, p < 0.05. Tukey's post hoc showed that HAP2 mice that received 1.5 mg/kg nicotine injections showed greater hour 1 alcohol intake (average across 10 days of treatment) than HAP2 mice that received 0.5 mg/kg nicotine injections (p < 0.05; Fig. 1B ). An analysis of line within each treatment showed that HAP2 mice consumed more alcohol (average across 10 days of treatment) than LAP2 mice in all treatment groups (ps < 0.05; Fig. 1B,C) .
The hour 2 ANOVA (line 9 treatment 9 day) yielded significant main effects of line, F(1, 85) = 67.1, p < 0.001, treatment, F(2, 85) = 3.1, p < 0.05, and day, F(9, 765) = 4.6, p < 0.001, and significant day 9 line, F(9, 765) = 4.5, p < 0.001, and line 9 treatment, F(2, 85) = 4.6, p < 0.05, interactions. The day 9 line interaction was due to a significant effect of day in HAP2 mice only, F(9, 396) = 5.2, p < 0.001. The line 9 treatment interaction was due to a significant main effect of treatment in HAP2 mice only (p < 0.05). Tukey's post hoc showed that HAP2 mice that received 1.5 mg/kg nicotine injections consumed more alcohol (average across 10 days of treatment) than HAP2 mice that received 0.5 mg/kg nicotine injections (p < 0.05; Fig. 1D ). An analysis of line within each treatment showed that HAP2 mice showed greater alcohol intake than LAP2 mice in all treatment groups (ps < 0.005; Fig. 1D,E) .
Given that it was previously found that a single acute injection of nicotine (0.5 mg/kg) decreased alcohol intake in C57BL/6J mice in a DID procedure (Hendrickson et al., 2009) , we also performed a within-subjects analysis comparing intake at both hours on the last habituation day to intake at both hours after the first nicotine/saline treatments (day 1) as another way to assess initial sensitivity to nicotine's effects on DID. We found that a 0.5 mg/kg nicotine injection on the first day significantly reduced hour 1 alcohol intake in HAP2 mice (Fig. 1B) . ANOVA on hour 1 data (line [2] 9 treatment [3] 9 day [2]) yielded significant main effects of line, F(1, 85) = 41.5, p < 0.001, and day, F(1, 85) = 17.2, p < 0.001, and a line 9 treatment 9 day interaction, F(2, 85) = 3.1, p < 0.05. Follow-up ANOVAs indicated a treatment 9 day interaction in HAP2 only, F(2, 42) = 3.7, p < 0.05. One-way ANOVA of treatment within each day in HAP2 mice indicated a treatment effect on the first day of treatment, F(2, 42) = 4.5, p < 0.05, and Tukey's post hoc analyses showed that alcohol intake in the 0.5 mg/kg nicotine group was significantly lower than the saline group (p < 0.05; Fig 1B) .
ANOVA on hour 2 data (line [2] 9 treatment [3] 9 day [2]) yielded a significant main effect of line only, F(1, 85) = 79.2, p < 0.001; HAP2 > LAP2 (Fig. 1D,E) .
DID
After 2-Week Abstinence Period (ReExposure). During re-exposure to DID following a 2-week abstinence period, HAP2 mice in the nicotine treatment groups generally showed greater hour 1 alcohol intake than HAP2 mice in the saline group. On day 1 of re-exposure, HAP2 mice in the 1.5 mg/kg nicotine group showed greater hour 1 alcohol intake than HAP2 mice in the saline and 0.5 mg/kg nicotine groups. On day 2 of re-exposure, HAP2 mice in the 0.5 mg/kg nicotine group showed greater hour 1 alcohol intake than HAP2 mice in the saline group (Fig. 1B) . Because we observed hour-dependent effects above, we analyzed alcohol intake in hours 1 and 2 separately. An ANOVA of line (2) 9 treatment (3) 9 day (2) on hour 1 alcohol intake during DID re-exposure yielded significant main effects of line, F(1, 38) = 116.7, p < 0.001, treatment, F(2, 38) = 5.3, p < 0.01, and day, F(1, 38) = 26.2, p < 0.001, and a significant day 9 line 9 treatment interaction, F(2, 38) = 5.0, p < 0.05. Follow-up ANOVAs indicated a significant treatment 9 day interaction, F(2, 18) = 6.6, p < 0.01, in HAP2 mice only. Follow-up analyses of treatment within each day yielded significant treatment effects on both days 1 (p < 0.05) and 2 (p < 0.01). On day 1 of re-exposure, Tukey's post hoc analyses showed that HAP2 mice that previously received 1.5 mg/kg nicotine injections consumed more alcohol than HAP2 mice that received saline (p = 0.06) or 0.5 mg/kg nicotine (p = 0.05). On day 2 of re-exposure, Tukey's post hoc showed that HAP2 mice that received 0.5 mg/kg nicotine injections consumed significantly more alcohol than HAP2 mice that received saline (p < 0.01). The difference in alcohol intake between the saline and 1.5 mg/kg nicotine groups was not significant (p = 0.09).
For hour 2 data, an ANOVA of line 9 treatment 9 day yielded significant main effects of line, F(1, 38) = 21.6, p < 0.001; HAP2 > LAP2, and treatment, F(2, 38) = 4.1, p < 0.05. Tukey's post hoc for treatment showed that mice in the 1.5 mg/kg nicotine group showed lower alcohol intake than mice in the saline group in hour 2 of re-exposure (p < 0.05; collapsed across line and day; Fig. 1D,E) .
Experiment 2: The Effects of Repeated Nicotine Injections on Immediate FC Drinking and on FC Drinking After a 2-Week Abstinence Period (Re-Exposure) FC Drinking Immediately After Nicotine or Saline Injections. Across 9 days of nicotine/saline treatment, HAP2 mice that received 1.5 mg/kg nicotine injections showed lower hour 3 alcohol intake and preference compared to HAP2 mice in the saline and 0.5 mg/kg nicotine groups (Fig. 2D,F) . ANOVAs of line (2) 9 treatment (3) 9 hour (3) 9 day (9) on alcohol intake and preference yielded significant main effects of line, F(1, 85) = 206.2 and 461.3, on intake and preference, respectively, ps < 0.001; HAP2 > LAP2, and a significant line 9 treatment 9 hour interaction, F(4, 170) = 6.0 and 4.6 for intake and preference, respectively, ps < 0.001 and 0.005. As there was no 4-way interaction with day, the alcohol intake and preference data were analyzed collapsed across days. Follow-up analyses of line 9 treatment within each hour (1, 2, and 3) postinjection yielded significant main effects of line (HAP2 > LAP2) at all 3 time points, F(1, 85) = 89.7, 206.0, 143.1 on intake, and 237.4, 248.5, 345.9 on preference, ps < 0.001 (Fig. 2B-G) . At hour 3 only, there was a significant main effect of treatment, F(2, 85) = 3.4, p < 0.05, for alcohol intake and significant line 9 treatment interactions for alcohol intake and preference, F(2, 85) = 5.7 and 7.7, ps = 0.005 and <0.001, respectively. Follow-up 1-way ANOVA of treatment on hour 3 alcohol intake and preference within each line yielded significant effects of treatment only in HAP2 mice, F(2, 40) = 4.0 and 5.4, ps < 0.05 and 0.01, respectively. Tukey's post hoc analysis showed that HAP2 mice that received 1.5 mg/kg nicotine showed lower alcohol intake and preference than HAP2 mice that received 0.0 and 0.5 mg/kg nicotine in the third hour postinjection (p < 0.05; Fig. 2D,G) . Analyses of line within each treatment showed that HAP2 mice showed significantly greater alcohol intake than LAP2 mice at all treatments (ps < 0.05; Fig. 2B-G) .
FC Drinking After 2-Week Abstinence Period (ReExposure). Nicotine treatment did not significantly affect alcohol intake or preference during re-exposure to FC drinking following a 2-week abstinence period (Fig. 2H,I ). ANOVAs of line (2) 9 treatment (3) 9 day (3) on alcohol intake and preference during re-exposure to FC drinking yielded significant main effects of line, F(1, 40) = 636.0 and 662.4, on intake and preference, respectively; ps < 0.001; HAP2 > LAP2, and a significant main effect of treatment, F (2, 40) = 4.8, p < 0.05, on alcohol intake. Tukey's post hoc analysis of treatment on alcohol intake collapsed by line did not yield any significant effects. However, the main effect of treatment appears to be due to increased alcohol intake in mice that received chronic nicotine and alcohol co-exposure. There were no significant effects of day on alcohol intake or preference (Fig. 2H,I ).
Experiment 3: The Effects of Chronic Nicotine Injections in Adolescent HAP2 and LAP2 Mice on Subsequent (Adult) FC Drinking and DID Nicotine treatment in HAP2 and LAP2 mice during adolescence did not affect alcohol intake in adulthood, as measured by FC drinking and DID (Fig. 3B-D ). An ANOVA of line (2) 9 treatment (3) 9 day (10) on FC alcohol intake and preference yielded significant main effects of line, F(1, 66) = 1,314.6 and 621.8, on intake and preference, respectively, ps < 0.001; HAP2 > LAP2 (Fig. 3B,C ). An ANOVA of line (2) 9 treatment (3) 9 day (5) on alcohol intake during the 5 days of DID also yielded a significant main effect of line, F(1, 65) = 166.5, p < 0.001; HAP2 > LAP2 (Fig. 3D ).
Experiment 4: The Effects of Chronic Nicotine Injections in Adult HAP2 Mice on Subsequent FC Drinking and DID
Nicotine treatment in adult HAP2 and LAP2 mice did not affect subsequent alcohol intake, as measured by FC drinking and DID (Fig. 4B-D ). An ANOVA of treatment (3) 9 day (9) on FC alcohol intake and preference did not show any main effects or interaction (Fig. 4B,C ). An ANOVA of treatment (3) 9 day (4) on DID alcohol intake showed a main effect of day only, F(3, 48) = 3.4, p < 0.05, driven by generally declining alcohol intake over days (Fig. 4D) .
DISCUSSION
Overall, we report that the effects of repeated nicotine injections on alcohol intake are dependent on temporal parameters, alcohol drinking paradigm, and genetic predisposition for alcohol preference. One main goal of this study was to compare the effects of repeated nicotine co-exposure on alcohol consumption (DID in Experiment 1 and FC in Experiment 2) with the effects of repeated nicotine preexposure in the absence of concurrent alcohol access (Experiments 3 and 4), using both binge-like and FC drinking procedures. We found that repeated nicotine and binge-like alcohol co-exposure increased binge-like alcohol intake in HAP2 mice during re-exposure to DID after a 2-week abstinence period (Experiment 1). However, repeated nicotine and FC alcohol co-exposure did not affect FC drinking after a 14-day abstinence period (Experiment 2). Repeated nicotine preexposure alone during adolescence (Experiment 3) or adulthood (Experiment 4) did not produce any effects on subsequent FC or binge-like drinking.
During the nicotine/saline treatment phase of Experiment 1, acute injection of nicotine (0.5 mg/kg) on day 1 decreased DID alcohol intake during hour 1 in HAP2 mice only. This finding is similar to those of Hendrickson and colleagues (2009) , who found that a single injection of nicotine (0.5 mg/ kg) decreased hour 1 DID alcohol intake in C57BL/6J mice. A possible explanation offered by the authors was that an acute nicotine pretreatment may have desensitized nicotinic acetylcholine receptors (nAChRs), which are important mediators of alcohol's reinforcing effects (Hendrickson et al., 2013) . Overall, averaged across 10 days of nicotine/ saline treatments, HAP2 mice that received 1.5 mg/kg nicotine had higher alcohol intake than mice that received 0.5 mg/kg nicotine injections in both hours 1 and 2 postinjection (Fig. 1B,D) . The reason for this outcome was due to the fact that alcohol intake in the 0.5 mg/kg group remained relatively low whereas intake in the 1.5 mg/kg group tended to increase across the 10 days of treatment (analyses indicated that neither nicotine group significantly differed from saline). One possible explanation for this finding is that the different doses of nicotine may have caused different adaptations of nAChRs, such as up-regulation/down-regulation of different nAChR subtypes and/or alterations of subunit composition (Govind et al., 2009 (Govind et al., , 2012 . Previous studies have shown that different nicotine treatment doses may result in different nAChR-mediated motivation-related outcomes such as dopamine neuron firing (Besson et al., 2007; Tolu et al., 2013) .
After 2 weeks of forced abstinence, in the first hour only on day 1 of re-exposure to DID, HAP2 mice with a history of 1.5 mg/kg nicotine treatment showed significantly elevated alcohol intake (compared to the saline group and 0.5 mg/kg group, which did not differ from saline). In the first hour only on day 2 of re-exposure to DID, all groups showed increased intake but intake in the nicotine-treated groups was higher than the saline-treated group, with a significant difference between the 0.5 mg/kg nicotine versus saline group. Interestingly, nicotine-treated groups in both lines (main effect of treatment) showed reduced alcohol intake in hour 2 of DID (collapsed across both re-exposure days). This intake behavior may be similar to the "front-loading" phenomenon observed following weeks of daily DID access in C57BL/6J mice. These animals shift overall intake to the beginning of the 2-hour daily access period, which may represent increased motivation and/or compulsion to consume alcohol (Linsenbardt and Boehm, 2014) . This interpretation is consistent with a recent finding in rats that chronic nicotine in alcohol-dependent rats increased motivation and compulsion to seek alcohol in an OSA paradigm (Leão et al., 2015) and supports studies in humans that show that binge drinking is highly associated with tobacco use (McKee and Weinberger, 2013) . However, a subsequent study by Linsenbardt and Boehm (2015) reported that the "front-loading" effect was not specific to alcohol because it was also observed in HAP1 mice that had repeated DID exposures to water only. Additional studies are necessary to characterize the specificity of the nicotine preexposure effect on DID alcohol drinking in HAP2 and HAP3 mice using other reinforcers like water and saccharin.
Nicotine injections produced some acute effects on FC drinking in Experiment 2. HAP2 mice that received 1.5 mg/ kg nicotine showed lower alcohol intake and preference than controls in the third hour postinjection. This is a novel finding because previous studies of immediate nicotine effects on alcohol drinking in mice have not measured alcohol intake beyond 2 hours postinjection (Sajja and Rahman, 2012) . The decreased alcohol intake in HAP2 mice is consistent with Sharpe and Samson (2002) , in which repeated nicotine injections immediately prior to alcohol OSA decreased both alcohol seeking and consumption in rats. The time-dependent effects of nicotine in this experiment are also reminiscent of studies in rats which found that an acute nicotine injection immediately prior to alcohol OSA decreased responding, but an acute nicotine injection 3 to 4 hours prior to alcohol OSA increased responding (Doyon et al., 2013; Hauser et al., 2012) .
Given the short half-life of nicotine in mice, it is important to note that the attenuating effect of nicotine on alcohol consumption 3 hours after injection observed in Experiment 2 may not be a direct effect caused by nicotine itself but rather by nicotine's primary metabolite, cotinine, which has a much longer half-life than nicotine (up to 1 hour in mice) and is available in high concentrations in the brain (Siu and Tyndale, 2007) . Cotinine has been shown to modulate nAChRs (Terry et al., 2015) , promote striatal dopamine release (Dwoskin et al., 1999) , and decrease impulsive-and compulsivelike behavior (Terry et al., 2012) . Given that alcohol consumption is modulated by nAChRs and the striatal dopamine system (Hendrickson et al., 2013) , and that high alcohol consumption is associated with high impulsivity (Oberlin and Grahame, 2009) , these effects of cotinine may reduce alcohol consumption.
Assuming that the mice in this study metabolized alcohol at a rate recorded previously (0.85 to 0.90 g/kg/h; Chester and Barrenha, 2007) , DID alcohol intake may have produced pharmacologically relevant BACs in LAP2 mice. Thus, the DID procedure may be a particularly useful model for exploring mechanisms regulating alcohol drinking in people without a genetic family history of AUDs. Although the DID procedure appears to have increased alcohol intake in LAP2 mice, HAP2 mice still drank double the amount of LAP2 mice. Similar findings in HAP1 and LAP1 mice tested in a DID procedure were previously reported (Crabbe et al., 2011) , showing that, not surprisingly, genetic mechanisms that underlie FC alcohol drinking also influence binge-like drinking.
Several other mechanisms may underlie nicotine's effects on alcohol drinking in HAP2 mice. Repeated nicotine exposure has been shown to produce cross-tolerance to alcohol and increased self-administration of alcohol, which can be mediated by metabolic enzymes and/or by alterations in synaptic plasticity in the brain (Abburi et al., 2016; Florek et al., 2015) . As mentioned above, a study recently showed that concurrent nicotine and alcohol exposure increases motivation for alcohol self-administration and compulsivelike drinking in rats. These behavioral findings were accompanied by nAChR-dependent activation of neuronal ensembles in stress-related brain areas such as central amygdala, dorsomedial prefrontal cortex, and bed nucleus of the stria terminalis (Leão et al., 2015) . The stress system, including the glucocorticoid system, plays an important role in nicotine's augmenting effects on alcohol self-administration (Doyon et al., 2013) and in the development of compulsivelike alcohol self-administration (Vendruscolo et al., 2012) .
HAP and LAP mouse lines differ in behavioral and hormonal response to stressors (Breit and Chester, 2016; Chester et al., 2014) . Notably, we have shown a strong inverse genetic correlation between propensity for high alcohol preference and corticosterone levels after footshock and conditioned fear-related stimuli (LAP1/2 > HAP1/2 lines; Chester et al., 2014) . Nicotine, like alcohol and other drugs of abuse, is a chemical stressor that stimulates the release of corticosterone (Armario, 2010) and it is possible that line differences in stress system responsivity to nicotine partly contribute to the observed line differences in sensitivity to nicotine's effect on alcohol drinking behavior.
Exposure to nicotine has been shown to produce crosssensitization to alcohol's rewarding effects (Biala and Budzynska, 2008) , perhaps by sensitizing midbrain dopamine neurons to alcohol's stimulating effects . The delayed nature of nicotine's effects on alcohol drinking suggests that alterations in gene expression may be involved. Nicotine exposure can alter epigenetic mechanisms that regulate a variety of genes, including the addictionrelated FosB gene (Nestler, 2001) . One study showed that nicotine exposure increased the ability of cocaine to increase FosB expression through inhibition of histone deacetylase (Levine et al., 2011) . Given that increased FosB expression increases the rewarding effects of drugs (Nestler, 2001) , alterations in epigenetic regulation of the FosB gene by nicotine and alcohol exposure may contribute to the increased alcohol drinking seen in Experiment 1. For further discussion on the molecular sites of nicotine-alcohol interactions, please refer to the following excellent reviews: Hendrickson and colleagues (2009) and Tarren and Bartlett (2017) .
Finally, another goal of the present study was to assess the effects of repeated nicotine preexposure during adolescence versus adulthood on alcohol drinking. We did not find any effects of repeated nicotine preexposure (injections) during adolescence (Experiment 3) or adulthood (Experiment 4) on either FC or binge-like drinking. This supports previous findings in rats (Kemppainen et al., 2009 ) but is inconsistent with the findings of Locker and colleagues (2016) in mice. Nicotine was injected by experimenters in the present study as well as in rats (Kemppainen et al., 2009) , who reported similar findings. On the other hand, mice received nicotine in their drinking water in Locker and colleagues (2016) . These differences in the mode of nicotine delivery may have produced different biological consequences that, in turn, produced different influences on alcohol drinking behaviors. For example, the chronic nature of nicotine access (22 h/d) in the study by Locker and colleagues (2016) may have resulted in a different pattern and/or level of nAChR up-regulation than repeated nicotine injections. A study previously showed that chronic nicotine delivery via osmotic minipumps results in greater up-regulation of nAChRs than repeated nicotine injections (Ulrich et al., 1997) . In addition, there was a gap of at least 14 days between the end of repeated nicotine exposure and the start of alcohol drinking procedures in the present study and in Kemppainen and colleagues (2009) , which may have permitted the reversal of neuroadaptations produced by chronic nicotine that may have altered subsequent alcohol drinking. In comparison, there was an overlap of 4 days between chronic nicotine preexposure in the drinking water and introduction of alcohol-containing bottles for 2 hours in Locker and colleagues (2016) . Further studies are needed to address these speculations.
It is important to note that the experiments in the present study were conducted in female mice, which often show greater responses to nicotine than males (see the Introduction); however, sex effects may be dependent on genotype (Bernardi et al., 2016) . Given the sex differences in nicotine sensitivity (see review by Pogun et al., 2017) and in nicotinealcohol interactions (see review by Adams, 2017) , future studies should include male subjects for comparison. In addition, we plan to test the effects of adolescent alcohol exposure on subsequent nicotine responses in HAP/LAP lines to shed additional light on age-related and genetic vulnerabilities associated with co-abuse of alcohol and nicotine. Finally, future work should build upon the current findings by examining nicotine-alcohol interactions in the replicate 3 HAP/ LAP selected lines to further support conclusions that nicotine's effects on alcohol drinking behaviors are regulated by genes selected for high or low alcohol preference. In summary, our results indicate that co-exposure to repeated nicotine injections and alcohol, but not repeated preexposure to nicotine alone (in adolescents or adults), increases binge-like alcohol intake in HAP2 but not LAP2 mice after a period of abstinence. These findings in selected mouse lines indicate that nicotine's effects on motivation to binge drink alcohol depend on genetic predisposition toward alcohol preference. Chronic binge drinking and tobacco use in humans with a genetic history of AUDs may lead to an escalation of subsequent binge drinking and more severe alcohol-related problems.
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